Post Market Surveillance
M2S can help transition your clinical trial from the development stage to the post-market surveillance stage. With over 10 years of experience in data and image management and analysis, M2S’ post-market registry is designed to be both flexible and scalable to ensure your needs are met. Through Clinical Data Pathways, M2S will provide access to the data, images, and analysis tools necessary to track your products' success over time.
-
Electronic Data Capture (EDC) for real-time data entry and efficiency
-
Risk-adjusted device performance monitoring
-
Adverse event reporting
- Analysis tools
- Access to clinical data and image data in one location
